1. Home
  2. VPG vs NMRA Comparison

VPG vs NMRA Comparison

Compare VPG & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VPG
  • NMRA
  • Stock Information
  • Founded
  • VPG 2009
  • NMRA 2019
  • Country
  • VPG United States
  • NMRA United States
  • Employees
  • VPG N/A
  • NMRA N/A
  • Industry
  • VPG Electrical Products
  • NMRA
  • Sector
  • VPG Technology
  • NMRA
  • Exchange
  • VPG Nasdaq
  • NMRA Nasdaq
  • Market Cap
  • VPG 293.3M
  • NMRA 287.6M
  • IPO Year
  • VPG N/A
  • NMRA 2023
  • Fundamental
  • Price
  • VPG $22.47
  • NMRA $1.16
  • Analyst Decision
  • VPG Hold
  • NMRA Buy
  • Analyst Count
  • VPG 1
  • NMRA 8
  • Target Price
  • VPG $31.00
  • NMRA $10.14
  • AVG Volume (30 Days)
  • VPG 69.9K
  • NMRA 1.3M
  • Earning Date
  • VPG 05-06-2025
  • NMRA 03-03-2025
  • Dividend Yield
  • VPG N/A
  • NMRA N/A
  • EPS Growth
  • VPG N/A
  • NMRA N/A
  • EPS
  • VPG 0.74
  • NMRA N/A
  • Revenue
  • VPG $306,522,000.00
  • NMRA N/A
  • Revenue This Year
  • VPG $2.60
  • NMRA N/A
  • Revenue Next Year
  • VPG $6.04
  • NMRA N/A
  • P/E Ratio
  • VPG $30.24
  • NMRA N/A
  • Revenue Growth
  • VPG N/A
  • NMRA N/A
  • 52 Week Low
  • VPG $20.83
  • NMRA $1.13
  • 52 Week High
  • VPG $35.52
  • NMRA $17.19
  • Technical
  • Relative Strength Index (RSI)
  • VPG 44.96
  • NMRA 26.07
  • Support Level
  • VPG $21.53
  • NMRA $1.13
  • Resistance Level
  • VPG $22.50
  • NMRA $1.23
  • Average True Range (ATR)
  • VPG 0.79
  • NMRA 0.12
  • MACD
  • VPG 0.01
  • NMRA 0.05
  • Stochastic Oscillator
  • VPG 54.68
  • NMRA 0.00

About VPG Vishay Precision Group Inc.

Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

Share on Social Networks: